APA

Mallalieu N. L., Wimalasundera S., Hsu J. C., Douglass W., Wells C., Penades I. C., Cuttica R., Huppertz H., Joos R., Kimura Y., Milojevic D., Rosenkranz M., Schikler K., Constantin T. & Wouters C. (20200210). Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. : Pediatric rheumatology online journal.

Chicago

Mallalieu Navita L, Wimalasundera Sunethra, Hsu Joy C, Douglass Wendy, Wells Chris, Penades Inmaculada Calvo, Cuttica Ruben, Huppertz Hans-Iko, Joos Rik, Kimura Yukiko, Milojevic Diana, Rosenkranz Margalit, Schikler Kenneth, Constantin Tamas and Wouters Carine. 20200210. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. : Pediatric rheumatology online journal.

Harvard

Mallalieu N. L., Wimalasundera S., Hsu J. C., Douglass W., Wells C., Penades I. C., Cuttica R., Huppertz H., Joos R., Kimura Y., Milojevic D., Rosenkranz M., Schikler K., Constantin T. and Wouters C. (20200210). Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. : Pediatric rheumatology online journal.

MLA

Mallalieu Navita L, Wimalasundera Sunethra, Hsu Joy C, Douglass Wendy, Wells Chris, Penades Inmaculada Calvo, Cuttica Ruben, Huppertz Hans-Iko, Joos Rik, Kimura Yukiko, Milojevic Diana, Rosenkranz Margalit, Schikler Kenneth, Constantin Tamas and Wouters Carine. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. : Pediatric rheumatology online journal. 20200210.